kelly: diverse patient input is necessary in the design of clinical trials
Published 11 months ago • 43 plays • Length 3:06Download video MP4
Download video MP3
Similar videos
-
2:27
the role clinical trials can play in metastatic breast cancer treatment | sheila mcglown
-
33:41
clinical trials for metastatic breast cancer: what you should know | dana-farber cancer institute
-
3:59
how clinical trials can treat metastatic breast cancer | christine hodgdon
-
57:39
clinical trials 101
-
12:27
chapter 7: designing clinical trials for metastatic breast cancer. metastatic breast cancer to the
-
5:26
nccn animation for patients: metastatic breast cancer testing explained
-
18:08
adolescent physical assessment- celebrity mcneal
-
38:21
complete physical exam i
-
31:53
lecture 2 - surrogate endpoints in oncology - reading and interpreting cancer trials
-
9:27
clinical trials during and after breast cancer
-
7:48
hologic ceo steve macmillan on breast cancer detection, future of ai-powered diagnostics
-
7:16
clinical trials and breast cancer | benefits to the patient
-
3:58
promise breast cancer clinical trial
-
4:09
why should metastatic breast cancer patients consider a clinical trial?
-
0:54
lack of diversity in cancer clinical trials: 2023 best of breast conference
-
3:49
clinical trials helping breast cancer patients
-
24:43
the importance of diversity in cancer clinical trials
-
51:39
webinar with prof cathy kelly: the importance of breast cancer clinical research in ireland
-
1:04:36
how patient advocates can help make clinical trials work better for everyone
-
1:15:58
diversity in breast cancer clinical trials
-
0:43
addressing the underrepresentation of ilc in clinical trials